- Home
- MNOV vs AXTI Comparison
MNOV vs AXTI Comparison
Compare MNOV & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- AXTI
- Stock Information
- Founded
- MNOV 2000
- AXTI 1986
- Country
- MNOV United States
- AXTI United States
- Employees
- MNOV N/A
- AXTI N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- AXTI Semiconductors
- Sector
- MNOV Health Care
- AXTI Technology
- Exchange
- MNOV Nasdaq
- AXTI Nasdaq
- Market Cap
- MNOV 87.3M
- AXTI 93.9M
- IPO Year
- MNOV 2005
- AXTI 1998
- Fundamental
- Price
- MNOV $2.15
- AXTI $2.21
- Analyst Decision
- MNOV Strong Buy
- AXTI Strong Buy
- Analyst Count
- MNOV 1
- AXTI 5
- Target Price
- MNOV $9.00
- AXTI $5.30
- AVG Volume (30 Days)
- MNOV 55.8K
- AXTI 356.8K
- Earning Date
- MNOV 11-13-2024
- AXTI 10-31-2024
- Dividend Yield
- MNOV N/A
- AXTI N/A
- EPS Growth
- MNOV N/A
- AXTI N/A
- EPS
- MNOV N/A
- AXTI N/A
- Revenue
- MNOV N/A
- AXTI $94,685,000.00
- Revenue This Year
- MNOV N/A
- AXTI $32.13
- Revenue Next Year
- MNOV N/A
- AXTI $12.84
- P/E Ratio
- MNOV N/A
- AXTI N/A
- Revenue Growth
- MNOV N/A
- AXTI 15.24
- 52 Week Low
- MNOV $1.12
- AXTI $1.73
- 52 Week High
- MNOV $2.55
- AXTI $5.64
- Technical
- Relative Strength Index (RSI)
- MNOV 54.08
- AXTI 56.22
- Support Level
- MNOV $2.07
- AXTI $2.16
- Resistance Level
- MNOV $2.48
- AXTI $2.32
- Average True Range (ATR)
- MNOV 0.11
- AXTI 0.14
- MACD
- MNOV -0.02
- AXTI 0.03
- Stochastic Oscillator
- MNOV 26.67
- AXTI 76.47
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About AXTI AXT Inc
AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.